Why does a patient on levothyroxine for five months have depression, tearfulness, and tremor despite a normal free T4 and a suppressed TSH of 0.17 mU/L?

Why Depression, Tearfulness, and Tremor Persist Despite Normal T4 and Suppressed TSH After 5 Months of Levothyroxine Overreplacement

Your patient is experiencing iatrogenic subclinical hyperthyroidism from levothyroxine overtreatment, and the suppressed TSH of 0.17 mU/L—despite being measured 2 weeks ago—indicates ongoing tissue exposure to excessive thyroid hormone that is directly causing the psychiatric and neurological symptoms. 1

The Core Problem: TSH Suppression Indicates Overtreatment

• A TSH of 0.17 mU/L falls below the normal reference range (0.45–4.5 mU/L) and represents iatrogenic subclinical hyperthyroidism, even though free T4 is currently "in range." 1
• The target TSH for primary hypothyroidism should be 0.5–4.5 mU/L with normal free T4; your patient's TSH of 0.17 is suppressed and indicates persistent overtreatment. 1
• Approximately 25% of patients on levothyroxine are unintentionally maintained on doses sufficient to fully suppress TSH, and this overtreatment directly causes psychiatric symptoms, tremors, and other manifestations of thyrotoxicosis. 1

Why Symptoms Persist Despite "Normal" T4

The Tissue Hyperthyroidism Explanation

• Free T4 being "in range" does NOT exclude tissue-level thyrotoxicosis—TSH is the most sensitive marker of thyroid hormone action at the tissue level, with 98% sensitivity and 92% specificity. 1
• The pituitary gland (which produces TSH) is exquisitely sensitive to even small elevations in thyroid hormone; a suppressed TSH of 0.17 indicates that tissues—including the brain—are exposed to excessive thyroid hormone. 1
• TSH may take longer to normalize than free T4 after dose adjustment, meaning the suppressed TSH reflects recent overexposure even if T4 has normalized in the past 2 weeks. 1

The Psychiatric Manifestation of Overtreatment

• Levothyroxine overdose directly causes psychiatric symptoms including depression, anxiety, emotional lability (tearfulness), and tremors—these are not coincidental but are direct manifestations of iatrogenic hyperthyroidism. 2
• A case report of a 26-year-old woman accidentally prescribed 300 mcg levothyroxine documented lethargy, tremors, body temperature dysregulation, and exacerbation of underlying psychiatric symptoms including depression and suicidal ideation. 2
• The paradox of "depression" in hyperthyroidism occurs because excessive thyroid hormone creates a hypermetabolic state that manifests as fatigue, emotional dysregulation, and anxiety—symptoms that overlap with depression. 2

The Autoimmune Neuroinflammation Factor

• If your patient has Hashimoto's thyroiditis (the most common cause of hypothyroidism), the autoimmune process itself may contribute to persistent psychiatric symptoms through inflammatory mediators affecting the brain, independent of thyroid hormone levels. 3
• Studies show that 63.5% of patients with subclinical hypothyroidism have depressive symptoms, with anxiety, somatization, cognitive impairment, psychomotor retardation, and sleep disorders being most prevalent. 4
• Levothyroxine replacement therapy alone is often ineffective in inducing total remission of depressive symptoms in patients with autoimmune thyroiditis, suggesting that the autoimmune process contributes to psychiatric manifestations. 4

Why the TSH Remains Suppressed After 2 Weeks

Pharmacokinetic Explanation

• Levothyroxine has a half-life of approximately 7 days, meaning it takes 6–8 weeks to reach steady state after any dose change; a TSH measured 2 weeks after stopping overreplacement still reflects the previous excessive dosing. 1
• Free T4 may normalize faster than TSH because the pituitary requires sustained euthyroid hormone levels before TSH secretion fully recovers. 1
• You must wait 6–8 weeks after dose adjustment to accurately assess whether TSH has normalized. 1

The Dose Was Likely Not Reduced Enough

• For TSH between 0.1–0.45 mU/L, the levothyroxine dose should be reduced by 12.5–25 mcg; for TSH <0.1 mU/L, reduce by 25–50 mcg immediately. 1
• If the dose was only stopped (rather than reduced and restarted at a lower dose), the patient may have resumed the same excessive dose after the "break," perpetuating the problem. 1

Immediate Management Algorithm

Step 1: Reduce Levothyroxine Dose Now

• Decrease the current levothyroxine dose by 12.5–25 mcg immediately to allow TSH to rise toward the reference range (0.5–4.5 mU/L). 1
• For a TSH of 0.17 mU/L, a reduction of 25 mcg is appropriate given the degree of suppression and the severity of symptoms. 1

Step 2: Recheck TSH and Free T4 in 6–8 Weeks

• Do not recheck thyroid function before 6–8 weeks, as this is the time required to reach steady state and accurately assess the new dose. 1
• Target TSH should be 0.5–4.5 mU/L with normal free T4. 1

Step 3: Address Psychiatric Symptoms Directly

• Recognize that the depression, tearfulness, and tremors are direct manifestations of iatrogenic hyperthyroidism and should improve within 6–8 weeks of normalizing TSH. 2
• Consider propranolol 10–20 mg twice daily to acutely manage tremors and anxiety symptoms while waiting for thyroid hormone levels to normalize. 2
• Do not assume these are primary psychiatric disorders requiring antidepressants—treat the thyroid overreplacement first. 2

Step 4: Psychiatric Evaluation if Symptoms Persist

• If depressive symptoms persist after TSH normalizes (6–8 weeks after dose adjustment), formal psychiatric evaluation is warranted, as autoimmune thyroiditis may contribute to persistent psychiatric symptoms independent of thyroid hormone levels. 4
• Studies show that levothyroxine replacement alone does not fully resolve depressive symptoms in many patients with Hashimoto's thyroiditis, suggesting a role for adjunctive psychiatric treatment. 4

Critical Pitfalls to Avoid

Do Not Assume "Normal T4" Means Adequate Treatment

• TSH is the primary marker for assessing levothyroxine dosing adequacy—a suppressed TSH indicates overtreatment regardless of free T4 level. 1
• Free T4 can be "in range" while TSH remains suppressed because the pituitary is more sensitive to thyroid hormone than peripheral tissues. 1

Do Not Wait for TSH to "Spontaneously Normalize"

• TSH will not normalize without dose reduction—the current dose is too high, and continuing it perpetuates the problem. 1
• About 25% of patients are unintentionally maintained on excessive doses; active dose reduction is required. 1

Do Not Overlook the Cardiovascular Risks

• Prolonged TSH suppression (even at 0.17 mU/L) increases the risk of atrial fibrillation 3–5 fold, especially in patients over 60 years, and is associated with increased cardiovascular mortality. 1
• Obtain an ECG to screen for atrial fibrillation, particularly if the patient has cardiac risk factors. 1

Do Not Dismiss the Bone Health Risks

• TSH suppression between 0.1–0.45 mU/L causes significant bone mineral density loss in postmenopausal women, increasing fracture risk. 1
• If your patient is postmenopausal, consider bone density assessment and ensure adequate calcium (1200 mg/day) and vitamin D (1000 units/day) intake. 1

The Bottom Line

Your patient's depression, tearfulness, and tremors are direct consequences of levothyroxine overtreatment, as evidenced by the suppressed TSH of 0.17 mU/L. The "normal" free T4 does not exclude tissue-level thyrotoxicosis because TSH is the most sensitive marker of thyroid hormone action. Reduce the levothyroxine dose by 25 mcg immediately, recheck TSH and free T4 in 6–8 weeks (not sooner), and expect psychiatric and neurological symptoms to improve as TSH normalizes. 1, 2 If symptoms persist after achieving euthyroidism, consider that autoimmune thyroiditis itself may contribute to psychiatric manifestations, warranting formal psychiatric evaluation. 4, 3